Blue Sail Medical Co., Ltd. 2025 Annual Report of Independent Director
Dear Shareholders and Representatives: Hello everyone!
As an independent director of Blue Sail Medical Co., Ltd. (hereinafter referred to as the "Company"), in accordance with the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Management Measures for Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Normative Operation of Main Board Listed Companies," and the "Articles of Association of Blue Sail Medical Co., Ltd." (hereinafter referred to as the "Articles of Association"), and the "Independent Director System" and other relevant laws, regulations, and rules, I have conscientiously, fairly, and independently fulfilled my duties with loyalty, diligence, and responsibility. In my work during 2025, I actively attended relevant meetings, carefully reviewed various proposals, and leveraged my independence and professional expertise to effectively protect the interests of the Company and its shareholders, especially small and medium investors. Here is a brief report on my work in 2025:
I. Basic Information
I, Zhao Yongqing, born in August 1972, am a Chinese national with no permanent overseas residency. I hold a Master's degree from Tongji University and an MBA from China Europe International Business School. I previously served as a director and secretary-general of the Education Development Foundation of China Europe International Business School, co-founder of the Qipu Leadership Innovation Workshop, and chief representative in China for the Shanghai American Business Center. I have focused on issues such as China's health and elderly care policies, innovative medical insurance payment models, medical device regulation, and challenges in hospital management and corporate compliance. I have brought together policy experts and industry leaders to build industry consensus and actively offer suggestions. I am currently an independent director of this Company and concurrently serve as a co-founder and deputy dean of the Shanghai Chuangqi Health Development Research Institute.
During the reporting period, my position complied with the independence requirements of the "Management Measures for Independent Directors of Listed Companies" and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Normative Operation of Main Board Listed Companies," and there were no circumstances that affected my independence.
II. Overview of Duty Performance
(I) Attendance at Board Meetings
In 2025, the Company held 20 board meetings. I was scheduled to attend 20 meetings, attended 1 meeting in person, participated in 18 meetings via communication, and entrusted 1 meeting to another director. I voted in favor of all proposals reviewed at these meetings, with no absences, actively fulfilling my duties as an independent director.
(II) Attendance at Shareholder Meetings
In 2025, the Company held 8 shareholder meetings, and I attended 7 of them. The convening and holding procedures of the Company's shareholder meetings complied with legal requirements.
I believe that the board meetings and shareholder meetings convened by the Company in 2025 complied with legal procedures. Major decision-making matters and other significant issues have undergone relevant procedures and are legal and effective. During the reporting period, all independent directors of the Company, in accordance with the "Articles of Association," "Rules of Procedure for Board Meetings," and the "Independent Director System," diligently reviewed all proposals submitted to the board for deliberation, safeguarding the overall interests of the Company and the legitimate rights and interests of small and medium shareholders.
(III) Attendance at Board Special Committees
- Nomination Committee
In 2025, as the chairman of the Sixth Board of Directors' Nomination Committee, I organized and convened 1 Nomination Committee meeting. The meeting reviewed proposals related to the appointment of the Company Secretary and other matters. We thoroughly understood the background of the candidates and the requirements of the proposed positions to determine if the candidates met the appointment criteria, and then submitted them to the board for deliberation, actively promoting the development of the Company's core team.